Overview of methimazole: mechanism of action and clinical applications

Thiamazole is an antithyroid drug primarily used to treat hyperthyroidism (hyperthyroidism). It inhibits thyroid peroxidase and reduces thyroid hormone synthesis, thereby alleviating the symptoms of hyperthyroidism. This article will cover the pharmacological effects, indications, usage and dosage, adverse reactions, and manufacturers to help readers fully understand the drug. The primary and secondary structure of the content is as follows: firstly, the core mechanism of action of the drug is introduced, secondly, clinical application and precautions are analyzed, and finally common brands and production information are listed.

Pharmacological effects and therapeutic principles

The core function of methimazole is to inhibit the synthesis of thyroid hormones. It blocks the activity of thyroid peroxidase, prevents the coupling of iodinated tyrosine, and reduces the production of thyroxine (T4) and triiodothyronine (T3). Compared with propylthiouracil, another commonly used drug, methimazole lasts longer and is usually given once daily. This drug is suitable for types of hyperthyroidism such as Graves' disease and toxic nodular goiter. However, it should be noted that it does not directly affect the release of synthesized hormones, so its effect requires waiting for the metabolism of the original hormones in the body to be completed.

Clinical applications and precautions

The initial dose of methimazole is usually 10-30 mg per day, which is adjusted according to the condition. Regular monitoring of thyroid function is required during treatment. Common adverse reactions include rash, joint pain, neutropenia, etc. In severe cases, it may cause liver damage or agranulocytosis, and the drug needs to be discontinued immediately and seek medical treatment. Pregnant and lactating women should use it with caution. If it must be used, the dosage should be adjusted under the guidance of a doctor. In addition, you should avoid foods high in iodine while taking the medicine to prevent it from affecting the efficacy of the medicine.

Adverse reactions and risk warnings

Although methimazole is highly effective, patients need to be wary of its potential risks. Mild rash or itching may occur in approximately 5% of patients, neutropenia may occur in 1%-3%, and in rare cases (0.2%-0.5%) severe liver damage may occur. Routine blood tests should be checked every week during the initial period of medication. If symptoms such as fever and sore throat occur, it may indicate agranulocytosis and require emergency treatment. Long-term users also need to monitor liver function and avoid combination with other hepatotoxic drugs.

Summary and production information

Methimazole is the first-line drug for the treatment of hyperthyroidism. Rational use can effectively control symptoms, but medical instructions must be strictly followed and adverse reactions must be monitored. Major domestic manufacturers include Beijing Yanjing Pharmaceutical (trade name "Thyrozol"), Germany's Merck (trade name "Thyrozol"), etc. Patients should pay attention to brand differences when choosing and ensure that the source of drugs is regular. The following is a partial production information table:

Quote sources:
1. "Guidelines for the Diagnosis and Treatment of Thyroid Disease in China" (Endocrinology Branch of the Chinese Medical Association, 2021)
2. American Thyroid Association (ATA) Clinical Practice Guidelines (2023 Update)
3. Drug instructions: Thyrozol (approval number H20140123), Thyrozol (import registration certificate number H20170245)